ALKERMES Inspiration Grants™ Awarded To Support People Affected by Mental Health & Substance Use Disorders

Alkermes plc, a global biopharmaceutical company developing medicines for the treatment of central nervous system (CNS) diseases, has announced that the company has awarded $1 million in funds to non-profit patient and community organizations as part of its newly launched ALKERMES Inspiration Grants™ program. The competitive grant program was designed to fund innovative and high-impact programs to support people affected by mental health and substance use disorders.

Awards went to large advocacy organizations, academic institutions and regional organizations. The selected programs include initiatives focused on peer support; connecting individuals to appropriate care, wellness and skill development in the . . .